Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
1-15 of 410
Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Project Oncology®Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Lajos Pusztai, MD, DPhil
Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Project Oncology®Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Lajos Pusztai, MD, DPhil
Exploring Combination Treatment in ER+/HER2- Breast Cancer
Project Oncology®Exploring Combination Treatment in ER+/HER2- Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Wassim Mchayleh, MD, MBA, FACP
Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Project Oncology®Emerging Endpoints for Evaluating Treatment Benefit in pLGG
Shelina Ramnarine, PhD
Mohamed Abdelbaki, MD
3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Project Oncology®3-Year FIREFLY-1 Findings in pLGG: A Look at Long-Term Outcomes
Alexandria May, PharmD, BCPS
Daniel Landi, MD
Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Project Oncology®Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD
- advertisement
What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Project Oncology®What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Petros Grivas, MD, PhD
Supporting Patients Throughout Urothelial Carcinoma Treatment
Project Oncology®Supporting Patients Throughout Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD
Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Project Oncology®Counseling Patients on Myelofibrosis Treatment Goals and Expectations
Shelina Ramnarine, PhD
John Mascarenhas, MD
Marina Kremyanskaya, MD
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Project Oncology®Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Steve Jackson, PharmD
Apar Kishor Ganti, MD
Thomas Marron, MD, PhD
Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Project Oncology®Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Charles Turck, PharmD, BCPS, BCCCP
Douglas A. Tremblay, MD
Real-World Outcomes with Axatilimab in cGVHD
Project Oncology®Real-World Outcomes with Axatilimab in cGVHD
Brian P. McDonough, MD, FAAFP
Hana Safah, MD
- advertisement
Axatilimab’s Impact on cGVHD and Associated BOS
Project Oncology®Axatilimab’s Impact on cGVHD and Associated BOS
Charles Turck, PharmD, BCPS, BCCCP
Amandeep Salhotra, MD
Current Approaches to Advanced Urothelial Carcinoma
Project Oncology®Current Approaches to Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Project Oncology®First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
